Table 2.
Mt. Sinai Sample | VALERO I | VALERO II | SCOPE | |||||||
---|---|---|---|---|---|---|---|---|---|---|
n=233 | n=195 | n=214 | n=179 | |||||||
Variable | ||||||||||
M | SD | M | SD | M | SD | M | SD | F | p | |
Everyday Functioning | ||||||||||
SLOF Interpersonal Functions | 29.78 | 5.37 | 24.84 | 6.31 | 22.45 | 5.97 | 23.03 | 6.23 | 72.02 | .001 |
SLOF Activities Subscale | 49.06 | 8.54 | 48.35 | 8.61 | 44.40 | 10.66 | 47.52 | 8.55 | 34.34 | .001 |
SLOF Vocational Subscale | 24.23 | 5.64 | 23.92 | 4.67 | 20.06 | 5.29 | 24.92 | 4.34 | 30.53 | .001 |
Predictor Variables | ||||||||||
Cognition Composite Score | 36.02 | 9.83 | 37.90 | 9.94 | 37.41 | 8.71 | 37.36 | 8.08 | 5.27 | .005 |
UPSA-B Score | 69.03 | 19.64 | 70.66 | 13.14 | 70.57 | 14.98 | 70.08 | 13.97 | 15.54 | .001 |
Negative Symptoms | 13.16 | 5.65 | 15.35 | 6.09 | 15.61 | 6.64 | 14.36 | 5.32 | 28.86 | .001 |
BDI-II | 11.90 | 10.07 | 15.80 | 12.02 | 15.33 | 11.68 | 16.83 | 12.18 | 56.24 | .001 |
Note. Mt. Sinai Patients are from New York; Valero I patients are from Atlanta and San Diego; Valero II patients are from Atlanta, San Diego, and Miami; SCOPE patients are from Miami and Dallas.